Redmond Asset Management, LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 22 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Redmond Asset Management, LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$883,963
-56.9%
137,689
-50.0%
0.29%
-19.2%
Q1 2023$2,051,566
+241.0%
275,378
+100.0%
0.36%
+64.4%
Q4 2022$601,701
-22.3%
137,6890.0%0.22%
-25.0%
Q3 2022$774,000
-2.8%
137,689
-0.2%
0.29%
+0.7%
Q2 2022$796,000
-43.1%
137,9420.0%0.29%
-31.4%
Q1 2022$1,399,000
+23.3%
137,942
+0.6%
0.42%
+31.5%
Q4 2021$1,135,000
+2.6%
137,098
+0.4%
0.32%
-8.4%
Q3 2021$1,106,000
+57.5%
136,593
+3.7%
0.35%
+68.0%
Q2 2021$702,000
+38.2%
131,7310.0%0.21%
+30.4%
Q1 2021$508,000131,7310.16%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 131,731$508,0000.16%
SABBY MANAGEMENT, LLC 160,182$618,0000.12%
ZEKE CAPITAL ADVISORS, LLC 45,000$174,0000.01%
Freedom Investment Management, Inc. 16,339$63,0000.01%
Virtu Financial LLC 15,121$58,0000.00%
TORONTO DOMINION BANK 12$00.00%
ROYAL BANK OF CANADA 17$00.00%
UBS Group AG 632$2,0000.00%
OSAIC HOLDINGS, INC. 6,012$23,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders